Results
1 -
10 of
56
(Click
here to explore results)
- Synthesis and characterization of biocompatible tigecycline imbibed electrospun poly ε-caprolactone urethane urea fibers. M. Sabitha, Sheeja Rajiv
, RSC Adv.
, 2015
, 5
, 2249
- Chimeric nanoparticles for targeting mitochondria in cancer cells. Aman Bajpai, Nakshi Nayan Desai, Shalini Pandey, Chinmayee Shukla, Bhaskar Datta, Sudipta Basu
, Nanoscale Adv.
, 2022
, 4
, 1112
- Recent advances in the rational design and optimization of antibacterial agents. Jesse A. Jones, Kristopher G. Virga, Giuseppe Gumina, Kirk E. Hevener
, Med. Chem. Commun.
, 2016
, 7
, 1694
- Curcumin assisted green synthesis of silver and zinc oxide nanostructures and their antibacterial activity against some clinical pathogenic multi-drug resistant bacteria. Noura El-Kattan, Ahmed N. Emam, Ahmed S. Mansour, Mostafa A. Ibrahim, Ashraf B. Abd El-Razik, Kamilia A. M. Allam, Nadia Youssef Riad, Samir A. Ibrahim
, RSC Adv.
, 2022
, 12
, 18022
- Development of a monoclonal antibody-based immunochromatographic strip for the rapid detection of tigecycline in human serum. Qianqian Lu, Xinxin Xu, Shanshan Song, Aihong Wu, Liqiang Liu, Hua Kuang, Chuanlai Xu
, Anal. Methods
, 2021
, 13
, 817
- Tocopherol polyethylene glycol succinate-modified hollow silver nanoparticles for combating bacteria-resistance. Xu-Qi Kang, Yue Qiao, Xiao-Yang Lu, Sai-Ping Jiang, Wei-Shuo Li, Xiao-Juan Wang, Xiao-Ling Xu, Jing Qi, Yong-Hong Xiao, Yong-Zhong Du
, Biomater. Sci.
, 2019
, 7
, 2520
- Circumventing challenges in mitochondrial targeting for cancer treatment: leveraging nanoplatforms for effective solutions. Shivani R. Pandya, Harjeet Singh, Martin F. Desimone, Jagpreet Singh, Noble George, Srushti Jasani
, Mater. Adv.
, 2024
, 5
, 409
- A call for action to the biomaterial community to tackle antimicrobial resistance. Thomas J. Hall, Victor M. Villapún, Owen Addison, Mark A. Webber, Morgan Lowther, Sophie E. T. Louth, Sophie E. Mountcastle, Mathieu Y. Brunet, Sophie C. Cox
, Biomater. Sci.
, 2020
, 8
, 4951
- Repurposing drugs against the main protease of SARS-CoV-2: mechanism-based insights supported by available laboratory and clinical data. Sohini Chakraborti, Sneha Bheemireddy, Narayanaswamy Srinivasan
, Mol. Omics
, 2020
, 16
, 474
- Semi-rational screening of the inhibitors and β-lactam antibiotics against the New Delhi metallo-β-lactamase 1 (NDM-1) producing E. coli. Juan Wang, Yang Li, Haizhong Yan, Juan Duan, Xihua Luo, Xueqin Feng, Lanfen Lu, Weijia Wang
, RSC Adv.
, 2018
, 8
, 5936